Review
Copyright ©The Author(s) 2022.
World J Gastroenterol. Jul 14, 2022; 28(26): 3047-3062
Published online Jul 14, 2022. doi: 10.3748/wjg.v28.i26.3047
Table 1 In vitro hepatoprotective effects of baicalin on different cell lines
Disease/type of study
Cell line
Dose
Mechanism/target pathways
Ref.
Palmitic acid-induced fatty liverAML-12 hepatocytes6.25-25 μMER stress↓; TXNIP/NLRP-3 pathway↓[50]
Hypoxic liver injury L02 human hepatocytes100 μmol/LCaspase-3, caspase-9, and Bax↓ [58]
Acetaldehyde induced EMTHepG2 cells20-100 mmol/LTGF-β/Smad pathway↓[59]
ns-PEF induced liver injuryL02 hepatocytes60 μMMTP stabilization, ROS↓[60]
Hemin-nitrite-H2O2 induced liver injuryHepG2 cells5 μM and 25 μMLipid peroxidation↓; GSH depletion↓[61]
PDGF-BB induced fibrosisHSCT6 hepatocytes150 μMmiR-3595↓; ACSL-4↑[69]
BDL-induced fibrosisHSCs67.5-270 μMWnt pathway↓; PPAR-γ↓[70]
LPS-induced hepatitisL20, THLE cell lines25-100 μMTUG-1↑; p38-MAPK↓; JNK pathway↓[82]
Viral hepatitisHuH7, HepG2 cells75 μg/mLNF-κB pathway↓[83]
pHBV1.2HepG2 cells10 μMHNF-4α/HNF-1α↓[84]
HepG2.2.15 cells10 μg/kgHBsAg, HBeAg↓[85]
PBMCs50-200 mg/mLMitochondrial pathway↑; Caspase 3↑[87]
HCCHepG2-HCC100 μmol/LER-mediated TF-6↑; S-2P protein↑[94]
SMMC7721-HCC cells160 μMCD47↓[95]
SMMC7721, HepG2-HCC cells40 μMSTAT3, IFN-γ↓; Block PDL-1/PD-1 pathway[96,97]